chr1-22637627-C-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_015991.4(C1QA):āc.11C>Gā(p.Pro4Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000522 in 1,613,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_015991.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1QA | NM_015991.4 | c.11C>G | p.Pro4Arg | missense_variant | 2/3 | ENST00000374642.8 | |
C1QA | NM_001347465.2 | c.11C>G | p.Pro4Arg | missense_variant | 2/3 | ||
C1QA | NM_001347466.2 | c.11C>G | p.Pro4Arg | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1QA | ENST00000374642.8 | c.11C>G | p.Pro4Arg | missense_variant | 2/3 | 1 | NM_015991.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000255 AC: 64AN: 250862Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135652
GnomAD4 exome AF: 0.000553 AC: 808AN: 1461774Hom.: 0 Cov.: 31 AF XY: 0.000499 AC XY: 363AN XY: 727176
GnomAD4 genome AF: 0.000230 AC: 35AN: 152164Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74336
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 05, 2022 | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 4 of the C1QA protein (p.Pro4Arg). This variant is present in population databases (rs149230484, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with C1QA-related conditions. ClinVar contains an entry for this variant (Variation ID: 1468526). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
C1Q deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Aug 28, 2019 | A heterozygous missense variant was identified, NM_015991.2(C1QA):c.11C>G in exon 2 of 3 of the C1QA gene. This substitution is predicted to create a major amino acid change from proline to arginine at position 4 of the protein, NP_057075.1(C1QA):p.(Pro4Arg). The proline at this position has low conservation (100 vertebrates, UCSC), and is located within the signal peptide motif. In silico software predictions of the pathogenicity of this variant are conflicting (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD population database at a frequency of 0.02% (68 heterozygotes, 0 homozygotes). An alternative residue change to serine at the same location has been reported in the gnomAD database at a frequency of 0.0004% (1 heterozygote, 0 homozygotes). The variant has not previously been reported in clinical cases. Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at